Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: Short-term and long-term effects on immunological and virological parameters

Perfusion

Volumn 17, Issue SUPPL., 2002, Pages 47-51

  Beretta, Alberto ^a   Hasson, Hamid ^a   Samiabadi, Abby ^a   Alfano, Massimo ^a   Trabattoni, Daria ^a   Lillo, Flavia ^a   Ferrante, Pasquale ^a   Clerici, Mario ^a   Lazzarin, Adriano ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; ANTIRETROVIRUS AGENT; CD45RA ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GRANULOCYTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGICAL PARAMETERS; LEUKAPHERESIS; LONG TERM CARE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SHORT COURSE THERAPY; T LYMPHOCYTE; TARGET CELL; VIRUS ACTIVATION; VIRUS REPLICATION; ANTIGEN EXPRESSION; APHERESIS; APHERESIS DEVICE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DNA DETERMINATION; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS; MEMORY T LYMPHOCYTE; PATIENT SAFETY; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ANTIGENS, CD45; ANTIGENS, CD95; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; GRANULOCYTES; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; LEUKAPHERESIS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 0036244936     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf559oa     Document Type: Article

References (17)

1. Decay characteristics of HIV-1-infected compartments during combination therapy
2. Molecular mechanisms for the regulation of HIV replication, persistence and latency
3. Infection of monocytes/ macrophages by human T lymphotropic virus type III
4. Quantification of latent tissue reservoires and total body viral load in HIV-1 infection
5. In vivo fate of HIV-1 infected T cells: Quantitative analysis of the transition to stable latency
6. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active antiretroviral theraphy
7. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy
8. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advance HIV disease
9. Patterns of T cell repopulation, viral load reduction and restoration of T cell function in HIV-infected persons during therapy with different antiretroviral agents
10. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB site long terminal repeat
11. Tumor necrosis factor (α,β) induced by HIV-1 in peripheral blood mononuclear cells potentiates virus replication
12. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
13. Tumor necrosis factor α/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages
14. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
15. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap columnb, G1
16. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
17. Identification of a reservoire for HIV-1 in patients on highly active antiretroviral therapy